UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Understanding the advantages and disadvantages of zero based budgeting can guide your financial choices. Make informed decisions for a better budget.
28,655 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
XRP tests the $1.40 support as bulls fight for momentum. Here are the three signals shaping its path this week.
Inflation pushes per-date costs toward $200, nudging Gen Z and millennials toward solo maxxing and away from traditio...
Micron Technology has surged 93% in the last month on AI data center demand. Investors weigh whether to lock in gains...
Investors are watching a busy 2026 IPO calendar as mega listings loom. Market watchers say AI momentum will shape dem...
FEZ investors see lumpy payouts tied to eurozone dividend calendars. This piece breaks down what that means for incom...
Investors over 50 are recalibrating away from crowded AI bets toward dividend growth and quality stocks that pay risi...
The INDS ETF blends self-storage and warehouse assets to offer a roughly 3.5% yield, presenting a mixed exposure that...
Ethereum wraps up Q2 with its third consecutive quarterly loss, signaling deeper trouble for the crypto market. Trade...
The NEOS Nasdaq-100 High Income ETF (QQQI) is delivering a high monthly payout via an option overlay, but the strateg...
Vertex’s $10 billion cash bid for Crinetics sparked a sharp rally, lifting the stock nearly to the offer price as tra...
A softer-than-expected June producer price index has traders pricing in earlier rate cuts, sending crypto markets hig...